Sarit E Assouline
13PUBLICATIONS
67CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Feb 05, 2026
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter transformation.Katharine Louise Lewis, Sarit E Assouline, Ross Ian Baker
|Jan 27, 2026
Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias.Sita Bhella, Gerard Agbayani, Katrina Hueniken
|Feb 26, 2025
The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL.Arnon P Kater, Rosemary Harrup, Thomas J Kipps
|Oct 24, 2024
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies.Laurie H Sehn, Nancy L Bartlett, Matthew J Matasar
|Aug 12, 2024
Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study.Andrée-Anne Pelland, Xavier Deschênes-Simard, Xavier Savard
Pageof 3
Frequent Collaborators
5 joint publications
Lihua E Budde
4 joint publications
Nancy L Bartlett
4 joint publications
Matthew J Matasar
3 joint publications
Chan Yoon Cheah
2 joint publications
Arnon P Kater
2 joint publications
Ian W Flinn
2 joint publications
Catherine Diefenbach
2 joint publications
Francesc Bosch
2 joint publications
John F Seymour
2 joint publications
Dok Hyun Yoon
